{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T09:27:17Z","timestamp":1784366837229,"version":"3.55.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,1,14]],"date-time":"2016-01-14T00:00:00Z","timestamp":1452729600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,1,14]],"date-time":"2016-01-14T00:00:00Z","timestamp":1452729600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:italic>In vitro<\/jats:italic> and <jats:italic>in vivo<\/jats:italic> experiments have shown that topical rebamipide will increase the number of goblet cells in the bulbar conjunctiva. The purpose of this study was to determine whether topical rebamipide will enhance the recovery of conjunctival goblet cells that were damaged during vitrectomy. Forty patients who underwent vitrectomy surgery were studied. The 40 patients consisted of 20 with diabetes mellitus (DM) and 20 patients without DM. They were randomized in a 1:1 ratio into groups that were treated or not treated with topical 2% rebamipide after the surgery. Impression cytology was performed at the end of surgery and at 14 days after the surgery. The mean goblet cell density of each specimen was determined by averaging the total number of goblet cells obtained from three consecutive high magnification microscopic images. In patients without DM, the mean goblet cell density at 14 days after the vitrectomy was significantly higher in eyes with topical rebemipide than in eyes without rebemipide (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.01). In patients with DM, a similar tendency was observed but the difference was not significant (<jats:italic>P<\/jats:italic>\u2009=\u20090.09). These results suggest that topical rebamipide can be helpful in patients with globlet cell damage that occur during and after vitrectomy.<\/jats:p>","DOI":"10.1038\/srep19516","type":"journal-article","created":{"date-parts":[[2016,1,14]],"date-time":"2016-01-14T14:14:44Z","timestamp":1452780884000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Effect of topical rebamipide on conjunctival goblet cell recovery after vitrectomy"],"prefix":"10.1038","volume":"6","author":[{"given":"Kumiko","family":"Kato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Takashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Matsunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiko","family":"Sugimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisashi","family":"Matsubara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Hirano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mineo","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,1,14]]},"reference":[{"key":"BFsrep19516_CR1","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/S0886-3350(00)00835-X","volume":"27","author":"JA Hovanesian","year":"2001","unstructured":"Hovanesian, J. A., Shah, S. S. & Maloney, R. K. Symptoms of dry eye and recurrent erosion syndrome after refractive surgery. J. Cataract. Refract. Surg. 27, 577\u2013584 (2001).","journal-title":"J. Cataract. Refract. Surg."},{"key":"BFsrep19516_CR2","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1097\/00055735-200108000-00013","volume":"12","author":"RT Ang","year":"2001","unstructured":"Ang, R. T., Dartt, D. A. & Tsubota, K. Dry eye after refractive surgery. Curr. Opin. Ophthalmol. 12, 318\u2013322 (2001).","journal-title":"Curr. Opin. Ophthalmol."},{"key":"BFsrep19516_CR3","doi-asserted-by":"publisher","first-page":"598","DOI":"10.3928\/1081-597X-20070601-11","volume":"23","author":"C Belmonte","year":"2007","unstructured":"Belmonte, C. Eye dryness sensations after refractive surgery: Impaired tear secretion or \u201cphantom\u201d cornea? J. Refract. Surg. 23, 598\u2013602 (2007).","journal-title":"J. Refract. Surg."},{"key":"BFsrep19516_CR4","first-page":"14","volume":"32","author":"CW Roberts","year":"2007","unstructured":"Roberts, C. W. & Elie, E. R. Dry eye symptoms following cataract surgery. Insight 32, 14\u201321 (2007).","journal-title":"Insight"},{"key":"BFsrep19516_CR5","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.1097\/ICO.0b013e31812f67ca","volume":"26","author":"XM Li","year":"2007","unstructured":"Li, X. M., Hu, L., Hu, J. & Wang, W. Investigation of dry eye disease and analysis of the pathogenic factors in patients after cataract surgery. Cornea 26, S16\u201320 (2007).","journal-title":"Cornea"},{"key":"BFsrep19516_CR6","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3341\/kjo.2009.23.2.65","volume":"23","author":"YK Cho","year":"2009","unstructured":"Cho, Y. K. & Kim, M. S. Dry eye after cataract surgery and associated intraoperative risk factors. Korean J. Ophthalmol. 23, 65\u201373 (2009).","journal-title":"Korean J. Ophthalmol."},{"key":"BFsrep19516_CR7","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/S0002-9394(14)77099-0","volume":"85","author":"FS Brightbills","year":"1978","unstructured":"Brightbills, F. S., Myers, F. L. & Bresnick, G. H. Postvitrectomy keratopathy. Am. J. Ophthalmol. 85, 651\u2013655 (1978).","journal-title":"Am. J. Ophthalmol."},{"key":"BFsrep19516_CR8","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1001\/archopht.1978.03910060155011","volume":"96","author":"HD Perry","year":"1978","unstructured":"Perry, H. D., Foulks, G. N., Thoft, R. A. & Tolentino, F. I. Corneal complications after closed vitrectomy through the pars plana. Arch. Ophthalmol. 96, 1401\u20131403 (1978).","journal-title":"Arch. Ophthalmol."},{"key":"BFsrep19516_CR9","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1007\/s004170100301","volume":"239","author":"H Heimann","year":"2001","unstructured":"Heimann, H., Coupland, S. E., Gochman, R., Hellmich, M. & Foerster, M. H. Alterations in expression of mucin, tenascin-c and syndecan-1 in the conjunctiva following retinal surgery and plaque radiotherapy. Graefes Arch. Clin. Exp. Ophthalmol. 239, 488\u2013495 (2001).","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"BFsrep19516_CR10","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1001\/archopht.1979.01020010530002","volume":"97","author":"GN Foulks","year":"1979","unstructured":"Foulks, G. N., Thoft, R. A., Perry, H. D. & Tolentino, F. I. Factors related to corneal complications after closed vitrectomy in diabetics. Arch. Ophthalmol. 97, 1076\u20131078 (1979).","journal-title":"Arch. Ophthalmol."},{"key":"BFsrep19516_CR11","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/S0161-6420(83)34540-1","volume":"90","author":"AP Schachat","year":"1983","unstructured":"Schachat, A. P., Oyakawa, R. T., Michels, R. G. & Rice, T. A. Complications of vitreous surgery for diabetic retinopathy: II. Postoperative complications. Opthalmology 90, 522\u2013530 (1983).","journal-title":"Opthalmology"},{"key":"BFsrep19516_CR12","first-page":"2915","volume":"41","author":"ME Rosenberg","year":"2000","unstructured":"Rosenberg, M. E. et al. Corneal structure and sensitivity in type 1 diabetes mellitus. Invest. Ophthalmol. Vis. Sci. 41, 2915\u20132921 (2000).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"BFsrep19516_CR13","first-page":"180","volume":"79","author":"RO Schultz","year":"1981","unstructured":"Schultz, R. O., Peters, M. A., Sobocinski, K., Nassif, K. & Schultz, K. J. Diabetic keratopathy. Trans. Am. Ophthalmol. Soc. 79, 180\u201399 (1981).","journal-title":"Trans. Am. Ophthalmol. Soc."},{"key":"BFsrep19516_CR14","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/S0161-6420(00)00599-6","volume":"108","author":"M Dogru","year":"2001","unstructured":"Dogru, M., Katakami, C. & Inoue, M. Tear function and ocular surface changes in noninsulin-dependent diabetes mellitus. Ophthalmology 108, 586\u201392 (2001).","journal-title":"Ophthalmology"},{"key":"BFsrep19516_CR15","first-page":"1038","volume":"116","author":"WL Chen","year":"2009","unstructured":"Chen, W. L. et al. In vivo confocal microscopic findings of corneal wound healing after corneal epithelial debridment in diabetic vitrectomy. Am. J. Ophthalmol. 116, 1038\u20131047 (2009).","journal-title":"Am. J. Ophthalmol."},{"key":"BFsrep19516_CR16","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3928\/1081-597X-20060101-13","volume":"22","author":"T Noda-Tsuruya","year":"2006","unstructured":"Noda-Tsuruya, T., Asano-Kato, N., Toda, I. & Tsubota, K. Autologous serum eye drops for dry eye after LASIK. J. Refract. Surg. 22, 61\u201366 (2006).","journal-title":"J. Refract. Surg."},{"key":"BFsrep19516_CR17","doi-asserted-by":"publisher","first-page":"473","DOI":"10.3928\/1081597X-20080501-04","volume":"24","author":"R Ursea","year":"2008","unstructured":"Ursea, R. et al. The effect of cyclosporine A (Restasis) on recovery of visual acuity following LASIK. J. Refract. Surg. 24, 473\u2013476 (2008).","journal-title":"J. Refract. Surg."},{"key":"BFsrep19516_CR18","first-page":"5S","volume":"43","author":"T Arakawa","year":"1998","unstructured":"Arakawa, T., Kobayashi, K., Yoshikawa, T. & Tarnawski, A. Rebamipide: overview of its mechanisms of action and efficacy in mucosal protection and ulcer healing. Dig. Dis. Sci. 43, 5S\u201313S (1998).","journal-title":"Dig. Dis. Sci."},{"key":"BFsrep19516_CR19","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1097\/01.ico.0000126436.25751.fb","volume":"23","author":"H Urashima","year":"2004","unstructured":"Urashima, H., Okamoto, T., Takeji, Y., Shinohara, H. & Fujisawa, S. Rebamipide increases the amount of mucin-like substances on the conjunctiva and cornea in the N-acetylcysteine-treated in vivo model. Cornea 23, 613\u2013619 (2004).","journal-title":"Cornea"},{"key":"BFsrep19516_CR20","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1089\/jop.2011.0147","volume":"28","author":"H Urashima","year":"2012","unstructured":"Urashima, H., Takeji, Y., Okamoto, T., Fujisawa, S. & Shinohara, H. Rebamipide increases mucin-like substance contents and periodic acid Schiff reagent-positive cells density in normal rabbits. J. Ocul. Pharmacol. Ther. 28, 264\u2013270 (2012).","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"BFsrep19516_CR21","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1097\/01.ico.0000208819.24990.0d","volume":"25","author":"JD R\u00edos","year":"2006","unstructured":"R\u00edos, J. D., Shatos, M., Urashima, H., Tran, H. & Dartt, D. A. OPC-12759 increases proliferation of cultured rat conjunctival goblet cells. Cornea 25, 573\u2013581 (2006).","journal-title":"Cornea"},{"key":"BFsrep19516_CR22","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.exer.2008.01.007","volume":"86","author":"JD R\u00edos","year":"2008","unstructured":"R\u00edos, J. D., Shatos, M. A., Urashima, H. & Dartt, D. A. Effect of OPC-12759 on EGF receptor activation, p44\/p42 MAPK activity and secretion in conjunctival goblet cells. Exp. Eye Res. 86, 629\u2013636 (2008).","journal-title":"Exp. Eye Res."},{"key":"BFsrep19516_CR23","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1016\/j.ophtha.2012.06.052","volume":"119","author":"S Kinoshita","year":"2012","unstructured":"Kinoshita, S. et al. Rebamipide Ophthalmic Suspension Phase II Study Group. Rebamipide (OPC-12759) in the treatment of dry eye: a randomized, double-masked, multicenter, placebo-controlled phase II study. Ophthalmology 119, 2471\u20132478 (2012).","journal-title":"Ophthalmology"},{"key":"BFsrep19516_CR24","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1016\/j.ophtha.2012.12.022","volume":"120","author":"S Kinoshita","year":"2013","unstructured":"Kinoshita, S. et al. Rebamipide Ophthalmic Suspension Phase 3 Study Group. A randomized, multicenter phase 3 study comparing 2% rebamipide (OPC-12759) with 0.1% sodium hyaluronate in the treatment of dry eye. Ophthalmology 120, 1158\u20131165 (2013).","journal-title":"Ophthalmology"},{"key":"BFsrep19516_CR25","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.ajo.2013.11.010","volume":"157","author":"S Kinoshita","year":"2014","unstructured":"Kinoshita, S. et al. Rebamipide Ophthalmic Suspension Long-term Study Group. A multicenter, open-label, 52-week study of 2% rebamipide (OPC-12759) ophthalmic suspension in patients with dry eye. Am. J. Ophthalmol. 157, 576\u2013583 (2014).","journal-title":"Am. J. Ophthalmol."},{"key":"BFsrep19516_CR26","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.exer.2003.09.009","volume":"78","author":"M Calonge","year":"2004","unstructured":"Calonge, M. et al. Impression cytology of the ocular surface: a review. Exp. Eye Res. 78, 457\u2013472 (2004).","journal-title":"Exp. Eye Res."},{"key":"BFsrep19516_CR27","doi-asserted-by":"publisher","first-page":"90S","DOI":"10.1023\/A:1018828105226","volume":"43","author":"A Tarnawski","year":"1998","unstructured":"Tarnawski, A., Arakawa, T. & Kobayashi, K. Rebamipide treatment activates epidermal growth factor and its receptor expression in normal and ulcerated gastric mucosa in rats: one mechanism for its ulcer healing action? Dig. Dis. Sci. 43, 90S\u201398S (1998).","journal-title":"Dig. Dis. Sci."},{"key":"BFsrep19516_CR28","first-page":"14S","volume":"43","author":"R Pai","year":"1998","unstructured":"Pai, R. & Tarnawski, A. Signal transduction cascades triggered by EGF receptor activation: relevance to gastric injury repair and ulcer healing. Dig. Dis. Sci. 43, 14S\u201322S (1998).","journal-title":"Dig. Dis. Sci."},{"key":"BFsrep19516_CR29","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1002\/jcp.10304","volume":"196","author":"LW Slice","year":"2003","unstructured":"Slice, L. W., Hodikian, R. & Zhukova, E. Gastrin and EGF synergistically induce cyclooxygenase-2 expression in Swiss 3T3 fibroblasts that express the CCK2 receptor. J. Cell Physiol. 196, 454\u2013463 (2003).","journal-title":"J. Cell Physiol."},{"key":"BFsrep19516_CR30","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/nm0302-289","volume":"8","author":"R Pai","year":"2002","unstructured":"Pai, R. et al. Prostaglandin E2 transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy. Nat. Med 8, 289\u2013293 (2002).","journal-title":"Nat. Med"},{"key":"BFsrep19516_CR31","doi-asserted-by":"publisher","first-page":"35451","DOI":"10.1074\/jbc.M302474200","volume":"278","author":"FG Buchanan","year":"2003","unstructured":"Buchanan, F. G., Wang, D., Bargiacchi, F. & DuBois, R. N. Prostaglandin E2 regulates cell migration via the intracellular activation of the epidermal growth factor receptor. J. Biol. Chem. 278, 35451\u201335457 (2003).","journal-title":"J. Biol. Chem."},{"key":"BFsrep19516_CR32","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1023\/B:DDAS.0000017439.60943.5c","volume":"49","author":"AS Tarnawski","year":"2004","unstructured":"Tarnawski, A. S., Chai, J., Pai, R. & Chiou, S. K. Rebamipide activates genes encoding angiogenic growth factors and Cox2 and stimulates angiogenesis: a key to its ulcer healing action? Dig. Dis. Sci. 49, 202\u2013209 (2004).","journal-title":"Dig. Dis. Sci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep19516.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep19516","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep19516.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T06:40:15Z","timestamp":1672900815000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep19516"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,14]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,5,10]]}},"alternative-id":["BFsrep19516"],"URL":"https:\/\/doi.org\/10.1038\/srep19516","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,14]]},"assertion":[{"value":"28 August 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19516"}}